We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Irinotecan in Treating Patients With Progressive or Recurrent Malignant Glioma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00003616
Recruitment Status : Completed
First Posted : February 9, 2004
Last Update Posted : December 16, 2008
Sponsor:
Collaborator:
Information provided by: